Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bay Area Biotech Roundtable: What Does It Take To Excel In The Global Marketplace? (Part 3 of 3)

This article was originally published in The Pink Sheet Daily

Executive Summary

Avigen, Genomic Health, Nuvelo, Poniard and Rigel execs sit down with "The Pink Sheet" DAILY to discuss Wall Street’s pipeline expectations, reducing R&D risk, and the California stem cell initiative.

You may also be interested in...



Bay Area Biotech Roundtable: What Does It Take To Excel In The Global Marketplace? (Part 2 of 3)

Avigen, Genomic Health, Nuvelo, Poniard and Rigel execs sit down with "The Pink Sheet" DAILY to discuss Asia, pharmacogenomics, and FDA's position on biomarkers.

Pfizer's Sutent Receives Dual Approvals For Kidney Cancer & Stomach Cancer

Pfizer's Sutent received accelerated approval for first-line treatment of advanced renal cell carcinoma and full approval for treatment of refractory gastrointestinal stromal tumors.

Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind

Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.

Topics

UsernamePublicRestriction

Register

OM006922

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel